Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipients.
about
Evaluation of pulmonary infiltrates in patients after stem cell transplantation.Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients.Comparison of quantitative cytomegalovirus real-time PCR in whole blood and pp65 antigenemia assay: clinical utility of CMV real-time PCR in hematopoietic stem cell transplant recipients.Quantification of cytomegalovirus viral load.Monitoring human cytomegalovirus infection with nested PCR: comparison of positive rates in plasma and leukocytes and with quantitative PCR.Detection of cytomegalovirus (CMV) DNA in EDTA whole-blood samples: evaluation of the quantitative artus CMV LightCycler PCR kit in conjunction with automated sample preparation.Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of CMV infection following lung transplantation.Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation.Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation.Algorithm based on CMV kinetics DNA viral load for preemptive therapy initiation after hematopoietic cell transplantation.A follow up study of cytomegalovirus infection in a group of Turkish renal transplant recipients using molecular assays.
P2860
Q36328397-E38E2756-60B2-455E-9E8D-D6D1E9A5F84FQ36933563-A0C07618-BF4E-4839-BF9C-E97717C27273Q37284695-BD67625B-6D7A-407A-80E4-7456101CFA42Q38171537-0ED24EC6-0C2B-4A2D-8221-99F552D884ABQ40182511-8FFC7055-7D52-4DE1-BA3C-6BF484CEE803Q43112358-3E518AA5-5765-43F6-95AA-D11D3CADF880Q45058851-592D7FCC-2FDA-4172-82F5-574DDAC6A83CQ45241091-768C441C-D0EB-4F78-8E8A-F6527D2D1113Q46987210-A7D87F73-8B3C-41B9-962B-67D27F2247F3Q51609961-D4686C9F-3960-4B12-B4DD-A9547811A0C9Q54647508-5A654307-E73C-4E9E-9E7C-E90E518B97A2
P2860
Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipients.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipients.
@ast
Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipients.
@en
Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipients.
@nl
type
label
Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipients.
@ast
Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipients.
@en
Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipients.
@nl
prefLabel
Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipients.
@ast
Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipients.
@en
Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipients.
@nl
P2093
P2860
P1476
Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipients.
@en
P2093
Adriana Weinberg
Debra Schissel
Roger Giller
P2860
P304
P356
10.1128/JCM.40.11.4203-4206.2002
P407
P577
2002-11-01T00:00:00Z